| 000 | 02452 a2200613 4500 | ||
|---|---|---|---|
| 005 | 20250518092154.0 | ||
| 264 | 0 | _c20201228 | |
| 008 | 202012s 0 0 eng d | ||
| 022 | _a1090-2104 | ||
| 024 | 7 |
_a10.1016/j.bbrc.2020.02.165 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInoue, Chisato | |
| 245 | 0 | 0 |
_aInvolvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _c05 2020 |
||
| 300 |
_a1074-1080 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCyclin D2 _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImatinib Mesylate _xpharmacology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
| 650 | 0 | 4 |
_aLeupeptins _xpharmacology |
| 650 | 0 | 4 |
_aMacrocyclic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 |
_aPhosphoinositide-3 Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Phosphatase 2 _xmetabolism |
| 650 | 0 | 4 |
_aProteolysis _xdrug effects |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
| 650 | 0 | 4 |
_aPyridazines _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aWortmannin _xpharmacology |
| 700 | 1 | _aSobue, Sayaka | |
| 700 | 1 | _aKawamoto, Yoshiyuki | |
| 700 | 1 | _aNishizawa, Yuji | |
| 700 | 1 | _aIchihara, Masatoshi | |
| 700 | 1 | _aAbe, Akihiro | |
| 700 | 1 | _aHayakawa, Fumihiko | |
| 700 | 1 | _aSuzuki, Motoshi | |
| 700 | 1 | _aNozawa, Yoshinori | |
| 700 | 1 | _aMurate, Takahsi | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 525 _gno. 4 _gp. 1074-1080 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2020.02.165 _zAvailable from publisher's website |
| 999 |
_c30752776 _d30752776 |
||